FOLLOW US :
  • |
  • |

Equity

Daily Market Tracker
Market Analysis
Other Markets
Corporate Actions
News
Corporate Information

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

ERIS Lifesciences LtdIndustry : Pharmaceuticals - Indian - Formulations
BSE Code:540596 P/E (TTM) :80.43
ISIN Demat:INE406M01024 Div & Yield %:0.44 EPS (TTM) :20.69
Book Value (RS) :203.3941378 Market Cap (Rs Cr.):22667.85 Face Value (RS) :1
    Change Company 
Particulars Quarter Ended
(Sep 2025)		 Quarter Ended
(Sep 2024)		 Quarter Ended
(% Var)
Sales 637.58 428.75 48.71
Other Income 23.59 5.81 306.02
PBIDT 320.47 148.44 115.89
Interest 46.50 56.26 -17.35
PBDT 273.97 92.18 197.21
Depreciation 39.30 46.16 -14.86
PBT 234.67 46.02 409.93
Tax 40.91 8.78 365.95
Deferred Tax 44.19 9.14 383.48
PAT 149.57 28.10 432.28

IMPORTANT LINKS

QUICK LINKS

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)